AUTH/3176/3/19: Orion Pharma – Sponsorship declarations in email and respiratory academy website

📅 2019 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/3176/3/19
CompanyOrion Pharma UK Limited
MaterialEmail and website (linking to an educational video hosted on a respiratory academy website)
Applicable Code year2016
Complaint received26 March 2019
Case completed02 October 2019
AppealNo appeal
Breach clauses9.1, 9.10
No breach clauses2, 4.1, 4.3, 4.4, 4.6, 4.8, 4.9, 12.1, 14.1
SanctionsUndertaking received; Additional sanctions: Not stated
Core issueDeclarations of sponsorship/involvement understated Orion’s role (commissioning vs “funding”)

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A UK health professional complained about an Orion Pharma UK email (sent via a healthcare publication) inviting recipients to watch a video on “Medicines optimisation and the clinical challenges in respiratory care”.
  • The email stated: “This campaign has been produced by [a named healthcare publisher] with funding from Orion Pharma” and linked directly to a respiratory academy website sponsored by Orion (among others).
  • The complainant alleged the email and linked website/videos were promotional but lacked prescribing information and adverse event reporting information, and suggested the set-up resembled disguised promotion via a supposedly independent platform.
  • Orion said it had commissioned the publisher to design, create and market a series of KOL-led educational videos; content was educational, not product-specific, hosted in a sponsored content section, and materials were certified.
⚖️

Outcome

  • No breach for allegations that the email, website, or the specific video were promotional requiring prescribing information/adverse event statement/date last drawn up (Clauses 4.1, 4.3, 4.4, 4.6, 4.8, 4.9).
  • Breach because declarations understated Orion’s involvement: Orion was more involved than “produced by publisher with funding from Orion” implied (Clauses 9.1 and 9.10).
  • No breach of disguised promotion (Clause 12.1) and certification (Clause 14.1).
  • No breach of Clause 2 (particular censure) in the circumstances.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training